Rockwell Medical, Inc. (Nasdaq: RMTI) announced that the FDA has approved the Company's Supplemental Abbreviated New Drug Application (sANDA) to ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE